title: Trastuzumab and lapatinib inHER2-positive metastatic colorectal cancer.
authors.affiliation: Department of Medical Oncology, Dr B.R. Ambedkar Institute Rotary Cancer Hospital All India Institute of Medical Sciences New Delhi, India.
authors.forename: Bivas
authors.initials: B
authors.lastname: Biswas
authors.affiliation: Department of Medical Oncology, Dr B.R. Ambedkar Institute Rotary Cancer Hospital All India Institute of Medical Sciences New Delhi, India.
authors.forename: Sameer
authors.initials: S
authors.lastname: Rastogi
authors.affiliation: Department of Medical Oncology, Dr B.R. Ambedkar Institute Rotary Cancer Hospital All India Institute of Medical Sciences New Delhi, India.
authors.forename: Atul
authors.initials: A
authors.lastname: Batra
authors.affiliation: Department of Medical Oncology, Tata Medical Centre, Kolkata, West Bengal, India.
authors.forename: Sandip
authors.initials: S
authors.lastname: Ganguly
mesh_terms: D000970:Antineoplastic Agents; D000971:Antineoplastic Combined Chemotherapy Protocols; D015179:Colorectal Neoplasms; D006801:Humans; D000077341:Lapatinib; D011799:Quinazolines; D000068878:Trastuzumab
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D000077341:Lapatinib; D000068878:Trastuzumab